Skip to main content
Clinical Trials/NL-OMON45631
NL-OMON45631
Recruiting
Not Applicable

Psychiatric and cognitive function in patients with Neuroendocrine tumours with carcinoid syndrome. - Psychiatric and cognitive function in patients with NET.

ederlands Kanker Instituut0 sites85 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cognitieve stoornissen
Sponsor
ederlands Kanker Instituut
Enrollment
85
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
ederlands Kanker Instituut

Eligibility Criteria

Inclusion Criteria

  • \- Patients with ileal NET with metastatic disease, diagnosed between 2012 and 2017
  • \- Signed informed consent

Exclusion Criteria

  • \- No sufficient understanding of the Dutch language.
  • \- A previous cerebro vascular accident (assessed through review of the chart and checked with the patient)
  • \- Severe cognitive problems such as a dementia.
  • \- Delirium in the past 3 months
  • \- Use of 5\-HT modulating medication, such as SSRIs or SNRIs, or tryptophan
  • \- Current chemotherapy, or chemotherapy in the past 5 years
  • \- Previous malignancy in the past 5 years, except for adequately treated basal cell carcinoma of the skin.
  • \- Life expectancy shorter than 3 months
  • \- Patients with a primary psychotic disorder (schizophrenia)

Outcomes

Primary Outcomes

Not specified

Similar Trials